Skip to main content
Premium Trial:

Request an Annual Quote

Eagle Genomics Closes $1.6M Fundraising Round

NEW YORK (GenomeWeb News) – Eagle Genomics, a UK-based bioinformatics software and services provider, has completed the second half of a round of fundraising, in which it raised a total of £1million ($1.6 million) that will be used to expand its offerings and develop new products.

Fundraising in the second half of the round was led by members of London Business Angels, with support from the Angel CoFund and from an investor from the first half, Jonathan Milner, who is the CEO of Abcam. In September, the company said that it had raised £590,000 ($917,000) during the first half of the round.

Eagle has said previously that it will use the funds to expand its current offerings, including further development of ElasticAP, its software-as-a-service subscription platform, and to expand its consulting business into markets such as consumer goods, food safety, and animal health.

"With the fundraising now secured, we can really begin to make progress in achieving our commercial goals," David Flanders, Eagle's CEO, said in a statement. "We have already begun our expansion, and the development of ElasticAP relationship is underway – all while we continue to grow the consulting side of the business."

The company added this week that it plans to double the size of its team —adding staff with experience in bioinformatics and software development — to enable it to meet the demands of developing ElasticAP and better support its client base.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.